Anagram Therapeutics, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Anagram Therapeutics, Inc.
Quantité totale PI 13
Rang # Quantité totale PI 119 789
Note d'activité PI 2/5.0    12
Rang # Activité PI 72 916
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

3 1
4 0
5 0
0
 
Dernier brevet 2025 - Methods and compositions for tre...
Premier brevet 2022 - Methods and compositions for tre...
Dernière marque 2023 - ANAGRAM THERAPEUTICS
Première marque 2023 - ANAGRAM THERAPEUTICS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Methods and compositions for treating congenital sucrase-isomaltase deficiency. e.g.e.ge.g., cong...
2023 Invention Methods and compositions for treating congenital sucrase-isomaltase deficiency. Disclosed are re...
Invention Methods and compositions for treating congenital sucrase-isomaltase deficiency. e.g.e.g., a recom...
Invention Methods and compositions for treating congenital sucrase-isomaltase deficiency
P/S Pharmaceutical preparations for the treatment of malabsorption syndromes, nutrient metabolism dis...
2022 Invention Engineered lipase enzymes, manufacture and use thereof. Provided are engineered lipase enzymes, ...
Invention Engineered lipase enzymes, manufacture and use thereof. Provided are engineered lipase enzymes, m...
Invention Methods and compositions for treating hyperglycemia and diabetes. Disclosed are pharmaceutical c...
Invention Methods and compositions for treating hyperglycemia and diabetes. e.g., e.g., a catalase enzyme),...
Invention Methods and compositions for treating fructose intolerance and fructose malabsorption. e.g., e.g....
Invention Methods and compositions for treating hyperglycemia and diabetes. Disclosed are pharmaceutical co...
Invention Methods and compositions for treating fructose intolerance and fructose malabsorption. Disclosed ...